Management of AIDS-Defining Cancers

  • Authors: David Aboulafia, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 4/9/18 (What's New)

References

Aboulafia DM. Regression of acquired immunodeficiency syndrome-related pulmonary Kaposi's sarcoma after highly active antiretroviral therapy. Mayo Clin Proc. 1998;73:439-443.[Aboulafia 1998]

Aboulafia DM, Pantanowitz L, Dezube BJ. AIDS-related non-Hodgkin’s lymphoma: still a problem in the era of highly active antiretroviral therapy. AIDS Read. 2004:14:605-617.[Aboulafia 2004]

Aboulafia DM, Puswella AL. Highly active antiretroviral therapy as the sole treatment for AIDS-related primary central nervous system lymphoma: a case report with implications for treatment. AIDS Patient Care STDS. 2007;21:900-907.[Aboulafia 2007]

Abraham AG, Strickler HD, Jing Y, et al. Invasive cervical cancer risk among HIV-infected women: A North American multi-cohort collaboration prospective study. J Acquir Immune Defic Syndr. 2013;62:405-413....

Action required

Keywords: Cancer

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.